Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant (SBRTvsTACE)
A Randomized Phase II Study of Individualized Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) With DEBDOX Beads as a Bridge to Transplant in Hepatocellular Carcinoma.
Sponsor: Lahey Clinic
A PHASE2 clinical study on HCC and Hepatocellular Carcinoma, this trial is completed. The trial is conducted by Lahey Clinic and has accumulated 11 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2022 — Apr 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 6 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Mar 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Mar 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jan 2018 [monthly]
Recruiting PHASE2
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lahey Clinic
- Varian Medical Systems
For direct contact, visit the study record on ClinicalTrials.gov .